Bolt Biotherapeutics BOLT Stock
Bolt Biotherapeutics Price Chart
Bolt Biotherapeutics BOLT Financial and Trading Overview
| Bolt Biotherapeutics stock price | 6.08 USD |
| Previous Close | 5.88 USD |
| Open | 6.03 USD |
| Bid | 5.95 USD x 1100 |
| Ask | 7.97 USD x 200 |
| Day's Range | 5.92 - 6.2 USD |
| 52 Week Range | 3.1 - 7.78 USD |
| Volume | 28.11K USD |
| Avg. Volume | 253.34K USD |
| Market Cap | 15.85M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -16.51 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BOLT Valuation Measures
| Enterprise Value | 18.04M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.30113918 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.3960965 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Bolt Biotherapeutics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 34.81% |
| S&P500 52-Week Change | 13.32% |
| 52 Week High | 7.78 USD |
| 52 Week Low | 3.1 USD |
| 50-Day Moving Average | 4.63 USD |
| 200-Day Moving Average | 4.5 USD |
BOLT Share Statistics
| Avg. Volume (3 month) | 253.34K USD |
| Avg. Daily Volume (10-Days) | 95.31K USD |
| Shares Outstanding | 2.61M |
| Float | N/A |
| Short Ratio | 0.08 |
| % Held by Insiders | 5.39% |
| % Held by Institutions | 36.82% |
| Shares Short | 47.38K |
| Short % of Float | 2.00% |
| Short % of Shares Outstanding | 2.00% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | September 30, 2026 |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -16.51 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 14.8M USD |
| Total Cash Per Share (mrq) | 7.53 USD |
| Total Debt (mrq) | 20.89M USD |
| Total Debt/Equity (mrq) | 243.97 USD |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 4.355 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Bolt Biotherapeutics
| Country | United States |
| State | CA |
| City | Redwood City |
| Address | 900 Chesapeake Drive |
| ZIP | 94063 |
| Phone | 650 665 9295 |
| Website | https://www.boltbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Bolt Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company offers product candidates and platform technologies, including PRA-216, BDC-4182, a Boltbody ISAC that targets the tumor-associated antigen claudin 18.2 for the treatment of gastric/gastroesophageal junction cancer, pancreatic cancer, and other tumor types; BDC-3042, a dectin-2 agonist antibody program for the treatment of non-small cell lung cancer, melanoma, and other solid tumors; the Boltbody Immune-Stimulating Antibody Conjugate (ISAC) platform, and the INSPIRE platform. It serves patients, clinical investigators, and biopharmaceutical partners. The company is based in Redwood City, California.
Q&A For Bolt Biotherapeutics Stock
What is a current BOLT stock price?
Bolt Biotherapeutics BOLT stock price today per share is 6.08 USD.
How to purchase Bolt Biotherapeutics stock?
You can buy BOLT shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bolt Biotherapeutics?
The stock symbol or ticker of Bolt Biotherapeutics is BOLT.
Which industry does the Bolt Biotherapeutics company belong to?
The Bolt Biotherapeutics industry is Biotechnology.
How many shares does Bolt Biotherapeutics have in circulation?
The max supply of Bolt Biotherapeutics shares is 2.61M.
What is Bolt Biotherapeutics Price to Earnings Ratio (PE Ratio)?
Bolt Biotherapeutics PE Ratio is now.
What was Bolt Biotherapeutics earnings per share over the trailing 12 months (TTM)?
Bolt Biotherapeutics EPS is -16.51 USD over the trailing 12 months.
Which sector does the Bolt Biotherapeutics company belong to?
The Bolt Biotherapeutics sector is Healthcare.
Bolt Biotherapeutics BOLT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
|
- | |||||
US Tech Composite
IXIC
US
|
25136.27 USD — |
-0.91
|
7.74B USD — | 24872.41 USD — | 25423.09 USD — | — - | 7.74B USD — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
4000.62 USD — |
-1.26
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
|
US Tech Global Select Market Com
NQGS
US
|
12378.66 USD — |
-0.9
|
— — | 12248.6 USD — | 12520.36 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
7211.27 USD — |
-0.5
|
— — | 7149.19 USD — | 7238.9 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1368.29 USD — |
-0.34
|
— — | 1358.68 USD — | 1373.65 USD — | — - | — — |
